Trial Profile
Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 15 Feb 2023
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Burns; Somatotropin deficiency
- Focus Therapeutic Use
- 10 Feb 2023 Status changed from active, no longer recruiting to completed.
- 18 Feb 2022 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2021 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.